Nutraceutical market consolidates with Finnish-Italian M&A

Milan 7.10.2025

Labomar Group acquires a majority of the Finnish Pharmia Holdling Oy, a leading manufacturing and CDMO company in the Nordics focusing on food supplements and probiotics. Pharmia has its head quarters in Tuusula, Finland and counts 85 employees today.  It has a 5000 sqm production site for compress, capsules and liquids.

This strategic acquisition enables the Italian Labomar Group to expand its presence in the Nordic countries characterised by highly promising growth rates. It marks an important step towards building an increasingly solid, innovative and international Group.

More info at: https://labomar.com/en/2025/10/02/labomar-group-accelerates-international-growth-welcome-pharmia/